Targeting the vascular tone of tumor microarterioles with an endothelin-1 antagonist selectively modulates tumor blood flow and improves response to treatments
(2004) 95th annual meeting of the American Association for Cancer Research (AACR) — Location: Orlando, FL (27.March.2004)
